Cypress Capital Management (Wyoming)’s Elevance Health ELV Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-795	Closed	-$110K	–	233
2016 Q1	$110K	Buy	795 +175	+28%	+$23.4K	0.15%	76
2015 Q4	$86.5K	Hold	620	–	–	0.11%	92
2015 Q3	$86.8K	Buy	620 +190	+44%	+$28.6K	0.11%	89
2015 Q2	$70.6K	Buy	430 +35	+9%	+$5.59K	0.08%	117
2015 Q1	$61K	Buy	+395	New	+$56.2K	0.07%	112

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s ELV Position: Q2 2016 in Review

Cypress Capital Management (Wyoming) sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 795 shares — an estimated $110K sold.

Cypress Capital Management (Wyoming) first reported a position in ELV in Q1 2015 and held it in 5 quarters. The position peaked at $110K in Q1 2016. 759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Cypress Capital Management (Wyoming) reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
Cypress Capital Management (Wyoming) sold 795 Elevance Health shares in Q2 2016, an estimated $110K.
Cypress Capital Management (Wyoming) first reported a position in Elevance Health in Q1 2015 and held it in 5 quarters.
Cypress Capital Management (Wyoming)'s Elevance Health position peaked at $110K in Q1 2016.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2016, filed 28 Jul 2016.